Rheumatology
More Senior Physicians See Fewer Underserved Patients
Findings for share of Medicaid patients and minority patients
Blacks More Likely to Have Disseminated Manifestations of Lyme Disease
Black patients have significantly longer median time to appropriate antibiotic treatment than Whites
ChatGPT Shows Poor Performance in Answering Drug-Related Questions
Nearly three-quarters of drug-related questions received no response or incomplete, wrong answers
CDC: Chronic Fatigue Syndrome Prevalence 1.3 Percent in 2021 to 2022
Higher prevalence seen for White non-Hispanic adults, adults with family income less than 100 percent of poverty level
Slow-to-Moderate Weight Loss Linked to Lower Mortality in Knee, Hip OA
Weight loss has dose-response protective effect on incident hypertension, type 2 diabetes, venous thromboembolism
White House Looks to Curb Big Pharma’s Sky-High Drug Prices
If a drug is too expensive, the Biden administration will use federal law to grant patent licenses to rival pharma companies
Many Patients of Color Expect and Prepare for Unfair Health Care
In a recent survey, 55 percent of Black respondents said they believe they must be careful about their appearance to get fair treatment in doctors' offices
Four JAK Inhibitors Have Comparable Efficacy, Safety for RA
Baseline CRP, Clinical Disease Activity Index, glucocorticoid dose predict resistance to CDAI-low disease activity achievement
CDC: 2021 to 2022 Saw Increase in U.S. Life Expectancy
Increase in life expectancy seen for males and females and for American Indian and Alaska Native, Hispanic, Black, Asian, White populations
Fourth COVID-19 Shot Beneficial in Patients With Autoimmune Rheumatic Diseases
Fourth dose reduces risk for SARS-CoV-2 for patients with systemic autoimmune rheumatic diseases using DMARDs
